Flack J - Search Results

1

Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis.

Feldman RD, Flack J, Howes L, Jenssen T, Reeves R, Shi H, Westergaard M, Hobbs FD; GEMINI US, GEMINI AALA, JEWEL 1 and 2 and CAPABLE investigators. Feldman RD, et al. Among authors: flack j. Curr Med Res Opin. 2012 Sep;28(9):1421-33. doi: 10.1185/03007995.2012.713339. Epub 2012 Aug 7. Curr Med Res Opin. 2012. PMID: 22809114

2

Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.

Larochelle P, Flack JM, Marbury TC, Sareli P, Krieger EM, Reeves RA. Larochelle P, et al. Among authors: flack jm. Am J Cardiol. 1997 Dec 15;80(12):1613-5. doi: 10.1016/s0002-9149(97)00784-4. Am J Cardiol. 1997. PMID: 9416950 Clinical Trial.

3

The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.

Raskin P, Guthrie R, Flack J, Reeves R, Saini R. Raskin P, et al. Among authors: flack j. J Hum Hypertens. 1999 Oct;13(10):683-7. doi: 10.1038/sj.jhh.1000888. J Hum Hypertens. 1999. PMID: 10516738 Clinical Trial.

4

Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial.

Flack JM, Victor R, Watson K, Ferdinand KC, Saunders E, Tarasenko L, Jamieson MJ, Shi H, Bruschi P. Flack JM, et al. Mayo Clin Proc. 2008 Jan;83(1):35-45. doi: 10.4065/83.1.35. Mayo Clin Proc. 2008. PMID: 18174006 Clinical Trial.

5

Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus.

Ferdinand KC, Flack JM, Saunders E, Victor R, Watson K, Kursun A, Jamieson MJ, Shi H. Ferdinand KC, et al. Among authors: flack jm. J Clin Hypertens (Greenwich). 2009 Oct;11(10):585-93. doi: 10.1111/j.1751-7176.2009.00062.x. J Clin Hypertens (Greenwich). 2009. PMID: 19817942 Free PMC article.

6

Hypertension therapy in the elderly.

Flack JM, McVeigh G, Grimm RH Jr. Flack JM, et al. Curr Opin Nephrol Hypertens. 1993 May;2(3):386-94. Curr Opin Nephrol Hypertens. 1993. PMID: 7922199 Review.

7

The Case for Low Blood Pressure Targets.

Flack JM, Nolasco C, Levy P. Flack JM, et al. Am J Hypertens. 2017 Jan;30(1):3-7. doi: 10.1093/ajh/hpw087. Epub 2016 Aug 29. Am J Hypertens. 2017. PMID: 27572960 Free PMC article. Review.

8

Optimal blood pressure on antihypertensive medication.

Flack JM. Flack JM. Curr Hypertens Rep. 1999 Oct;1(5):381-6. doi: 10.1007/s11906-999-0052-3. Curr Hypertens Rep. 1999. PMID: 10981094

9

Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage.

Flack JM, Mensah GA, Ferrario CM. Flack JM, et al. Curr Med Res Opin. 2000;16(2):66-79. Curr Med Res Opin. 2000. PMID: 10893650 Review.

10

Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.

Levy PD, Willock RJ, Burla M, Brody A, Mahn J, Marinica A, Nasser SA, Flack JM. Levy PD, et al. Among authors: flack jm. J Am Soc Hypertens. 2016 Dec;10(12):906-916. doi: 10.1016/j.jash.2016.10.005. Epub 2016 Oct 28. J Am Soc Hypertens. 2016. PMID: 27856202 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

482 results

Search Page